Tablets Neobutin 200 mg, # 30
Category
Preparations for the gastrointestinal tract
Scope of the drug
Gastrointestinal tract
Release form
Tablet
Manufacturer country
Russia
Package quantity, pcs
thirty
Neobutin tab.
200mg No. 30
Name ENG
NEOBUTIN
Clinical and pharmacological group
A drug that regulates the motor function of the gastrointestinal tract
ATX code
Trimebutine
Dosage
200mg
Structure
1 tablet contains:
.active substance: trimebutine maleate 200 mg excipients: lactose monohydrate 81.6 mg, corn starch 32 mg, colloidal silicon dioxide (aerosil) 3.2 mg, magnesium stearate 3.2 mg.
Indications
Irritable Bowel Syndrome.
Postoperative paralytic intestinal obstruction.
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 3 years
Contraindications
Hypersensitivity to trimebutin maleate and other components that make up the drug.
Children under 3 years of age (for this dosage form).
Pregnancy.
Lactose intolerance, lactase deficiency, glucose-galactose malabsorption.
INN / Active ingredient
Trimebutin
Specifications
Category
Preparations for the gastrointestinal tract
Scope of the drug
Gastrointestinal tract
Release form
Tablet
Manufacturer country
Russia
Package quantity, pcs
thirty
Scope of application
Gastroenterology
Minimum age from
3 years old
Way of introduction
Through the mouth
Vacation conditions
Without recipe
Brand name
Obolenskoe farm.
company
The amount of the dosage form in the primary package
10 pieces.
Primary packaging type
Blister
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Antispasmodic
Anatomical and therapeutic characteristics
A03AA05 Trimebutin
Dosage form
Pills
Expiration date in days
1095
Dosage (volume) of the substance in the preparation
trimebutine maleate 200 mg
Package weight, g
thirty
Mode of application
:
Inside, before meals.
< br> Adults and children over 12 years old: 100-200 mg 3 times a day.
< br> To prevent recurrence of irritable bowel syndrome after the course of treatment during the period of remission, it is recommended to continue taking the drug at a dose of 300 mg per day for 12 weeks.
< br> Children aged 5-12 years: 50 mg 3 times a day.
< br> Children aged 3-5 years: 25 mg 3 times a day.